Therefore, to consider the impact of differences in proliferation of these cell lines on the results of siRNA screening, we also examined SMARCB1-proficient HEK293T immortalized cell lines and five SMARCB1-proficient cancer cell lines. This evidence concerns the gene SMARCB1 and cancer.